No Detail Found!

Valproic acid improves nerve injury in young rats with epilepsy by regulating stxbp1

Author(s)
S. Guihai Department of Pediatrics, Affiliated Hospital of Nantong University ,China
W. Xiaolin Department of Pediatrics,Affiliated Rudong Hospital of Xinglin College,Nantong University , China
D. Yufei Nantong University ,China
W. Youjia Department of Pediatrics, Affiliated Hospital of Nantong University ,China
L. Haiying Department of Pediatrics, Affiliated Hospital of Nantong University ,China
Z. Yuqin Department of Pediatrics, Affiliated Hospital of Nantong University ,China
Abstract
This study aims to discuss how valproic acid improves nerve injury in young rats with epilepsy by regulating STXBP1. It also seeks to identify risk proteins for epilepsy through bioinformatics analysis. 30 young rats were divided into three groups, namely Normal, Model, and VA. Each group contained 10 rats. Epilepsy models were established in all groups except the control group. After modeling, the valproic acid group was orally administered 1 mg/kg of valproic acid. Cognitive function was assessed using the water maze experiment, while hippocampal tissue morphology was observed through Nissl staining. The neuronal apoptosis rate in hippocampal tissue was detected using the TUNEL method. Immunohistochemical staining was performed to detect the NMDARl-positive cell rate in hippocampal tissue. Meanwhile, immunoblotting was used to measure the expression levels of STXBP1 and SLC2A1p proteins in hippocampal tissue. Bioinformatics analysis identified STXBP1 as a risk protein for epilepsy. Compared to the control group, the platform search time, neuronal apoptosis rate, NMDARl-positive cell rate, number of crossing platforms, and proportion of original platform search time in the model group of young mice decreased on days 1, 2, 3, and 4 (P=0.001). In addition, the levels of STXBP1 and SLC2A1 proteins decreased (P=0.001). In comparison to the model group, platform search time, neuronal apoptosis rate, and NMDAR1-positive cell rate in the valproic acid group of young mice decreased on days 1, 2, 3, and 4. However, the number of crossing platforms and the proportion of original platform search time increased (P=0.001). In addition, the levels of STXBP1 and SLC2A1 proteins significantly increased (P=0.001). In conclusion, valproic acid can significantly improve cognitive function, reduce the expression of NMDAR1, and inhibit neuronal apoptosis in juvenile epileptic rats. The mechanism might be related to its regulation of STXBP1 expression.
Publication Details
Page(s) 1050-1059
Published Journal: Journal of Animal and Plant sciences, Volume: 35, Issue: 4, Year: 2025

Request the full text from PASTIC

Keywords
Epilepsy, valproic acid, STXBP1, Cognitive function
References
Ancora C.,J.D. M.A.,Valletti F.,Furia J.E.K.,Nielsen R.S.,Møller R.S.,Gardella R.S. .2024 .Emergence of lingual dystonia and strabismus in early-onset SCN8A selflimiting familial infantile epilepsy. Epileptic Disord, 10(2) : 20203-224.
de Bartolomeis C.,Avagliano L.,Vellucci L.,D'Ambrosio M.,Manchia M.,G. D'Urso E.F.,Buonaguro F.,Iasevoli F. .2019 .Translating preclinical findings in clinically relevant new antipsychotic targets: focus on the glutamatergic postsynaptic density. Implications for treatment resistant schizophrenia. Neurosci. Biobehav. Rev, 08 : 795-827.
Fotopoulos N.H.,Chaumette B.,Devenyi G.A.,Karama S.,Chakravarty M.,Labbe A.,Grizenko N.,Schmitz N.,Fageera W.,Joober R. .2024 .Maternal smoking during pregnancy and cortical structure in children with attentiondeficit/hyperactivity disorder. Psychiatry Res, 115791 : .
Howden C.W.,Cook E.E.,Swallow E.,Yang K.,Guo H.,Pelletier C.,Jacob R.,Sugano K. .2023 .Real-world outcomes associated with vonoprazan-based versus proton pump inhibitorbased therapy for Helicobacter pylori infection in Japan. Therap Adv Gastroenterol, 10 : .
Liu S.,Wang L.,Cai X.T.,Zhou H.,Yu D.,Wang Z. .2018 .Therapeutic benefits of ACTH and levetiracetam in STXBP1 encephalopathy with a de novo mutation: a case report and literature review. Medicine (Baltimore), 10(18) : .
Li X.,Liu Y.,Wang S.,Jiang Y.,Algradi A.M.,Zhou Y.,Pan J.,Guan W.,Kuang H.,Yang B .2022 .The aerial parts of Bupleurum Chinense DC. aromatic oil attenuate kainic acid-induced epilepsy-like behavior and its potential mechanisms. Biomed. Res. Int. 2022 Apr, 10 : .
Li Y.L.,Liu F.,Zhang Y.Y.,Lin J.,Huang C.L.,Fu M.,Zhou C.,Li C.J.,Shen J.F. .2021 .NMDAR1-Src-Pannexin1 signal pathway in the trigeminal ganglion contributed to orofacial ectopic pain following inferior alveolar nerve transection. Neuroscience, 04 : 77-86.
Ma L.,Rebane A.A.,Yang G.,Xi Z.,Kang Y.,Gao Y.,Zhang Y. .2015 .Munc18-1-regulated stage-wise SNARE assembly underlying synaptic exocytosis. Elife, 10 : .
MacLean A.,Chappell A.S.,Kranzler J.,Evrard A.,Monchal H.,C. H. . .a selective potentiator of alpha2- and alpha3- containing GABA(A) receptors, fully suppresses spontaneous cortical spike-wave discharges in Genetic Absence Epilepsy Rats from Strasbourg (GAERS). Drug Dev Res, 10(2) : .
Park Y.,Lee H.J.,Sim D.Y.,Park J.E.,Ahn C.H.,Park S.Y.,Lee Y.C.,Shim B.S.,Kim B.,Kim S.H. .2024 .Inhibition of glycolysis and SIRT1/GLUT1 signaling ameliorates the apoptotic effect of Leptosidin in prostate cancer cells. Phytother Res, 10(3) : 1235-1244.
Romaniello R.,Saettini F.,Panzeri E.,Arrigoni F.,Bassi M.T.,Borgatti R. .2015 .A de-novo STXBP1 gene mutation in a patient showing the Rett syndrome phenotype. Neuroreport, 10(5) : 254-7.
Rostami F.,Suha A. Jaafari,Janahmadi M.,N. M. .2024 .Hosseinmardi (20240. Aquaporin-4 inhibition attenuates Pentylenetetrazole-induced behavioral seizures and cognitive impairments in kindled rats. Physiol Behav, 114521 : .
Saitsu H.,Kato M.,Mizuguchi T.,Hamada K.,Osaka H.,Tohyama J.,Uruno K.,Kumada S.,Nishiyama K.,Nishimura A.,Yoshimura Y.,Hirai S.,Kumada T.,Hayasaka K.,Fukuda A.,Ogata K.,Matsumoto N. .2008 .De novo mutations in the gene encoding STXBP1 (MUNC18-1) cause early infantile epileptic encephalopathy. Nat Genet, 10(6) : 782-8.
Sherman B.T.,Hao M.,Qiu J.,Jiao X.,Baseler M.W.,Lane H.C.,Imamichi T.,Chang W. .2022 .DAVID: a web server for functional enrichment analysis and functional annotation of gene lists (2021 update). Nucleic Acids Res, 10(W1) : W216-W221.
Singh G.,Sander J.W. .2020 .The global burden of epilepsy report: implications for low- and middle-income countries. Epilepsy Behav, 106949 : .
Stamberger S.,Weckhuysen and P. De Jonghe S. .2017 .STXBP1 as a therapeutic target for epileptic encephalopathy. Expert Opin Ther Targets, 1386175(11) : 1027-1036.
Stepien K.P.,Rizo K.P.,- K.P. .2021 .-dependent liposome fusion with a few neuronal SNAREs. Proc. Natl. Acad. Sci, 10(4) : .
Steriade C.,M.J. Titulaer A.,Vezzani J.W.,Sander and R.D. Thijs J.W. .2021 .The association between systemic autoimmune disorders and epilepsy and its clinical implications. Brain, 10(2) : 372-390.
Syrbe S.,Hedrich U.B.S.,Djémié T.,Müller S.,Møller R.S.,Maher B.,Caglayan H.S.,Arslan M.,Serratosa J.M.,Nothnagel M.,Krause R.,Löffler H.,Detert K.,Dorn T.,Vogt H.,Krämer G.,Schöls L.,Mullis P.E.,Linnankivi T.,Lehesjoki A.E.,Sterbova K.,Craiu D.C.,Hoffman-Zacharska D.,Korff C.M.,Weber Y.G.,Steinlin M.,Gallati S.,Bertsche A.,Bernhard M.K.,Merkenschlager A.,Gonzalez M.,Züchner S.,Palotie A.,Suls A.,Biskup S.,Wolff M.,Maljevic S.,Schüle R.,Sisodiya S.M.,Weckhuysen S.,Lerche H.,Lemke J.R. .2015 .De novo loss- or gain-of-function mutations in KCNA2 cause epileptic encephalopathy. Nat. Genet, 10(4) : 393-399.
Wang H.,Zhao Y.,Zhang D.,Li J.,Yang K.,Yang J.,Li B. .2024 .Neuroprotective effects of quinpirole on lithium chloride pilocarpineinduced epilepsy in rats and its underlying mechanisms. Eur. J. Med. Res, 10(1) : 121.
Xie H.,Zhou R.,Fang J.,Zhuang J.,Wen M.,Yang J,He J .2023 .Rapamycin plays an anti-epileptic role by restoring blood-brain barrier dysfunction, balancing T cell subsets and inhibiting neuronal apoptosis. Discov Med, 202335179(179) : 1043-1051.
Zhang Y.H.,Liu X.S.,Gao Y.,Yuan L.L.,Zhang Y.,Liu Z.Y.,Yang Y.,Liu X.Y.,Ke C.B.,ZJ Z.J. Pei .2023 .SFXN1 as a potential diagnostic and prognostic biomarker of LUAD is associated with (18)F-FDG metabolic parameters. Lung Cancer, 107449 : .
0

Citations

0

Downloads

17

Views